Tecan, CH0012100191

Tecan stock holds recent gains as investors focus on latest earnings trends

Published on 09/17/2026 at 13:16 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Tecan stock recently closed at about CHF 204.00 on the SIX Swiss Exchange on September 15, 2026, reflecting a 3.6 percent gain versus the prior session. The shares remain supported by the company’s latest reported revenue and profitability trends from its most recent results.

Fotorealistisches Laborautomationsgerät mit Pipettierarm über Mikroplatten in modernem Labor
Tecan Group AG (CH0012100191) zeigt Laborautomation: automatisierter Pipettierroboter verarbeitet Mikroplatten in modernem Forschungslabor präzise, Illustration mit AI erstellt.

Tecan AG stock (ISIN CH0012100191) most recently closed at about CHF 204.00 on the SIX Swiss Exchange on September 15, 2026, representing a 3.6 percent increase compared with the previous session’s close, according to Swiss market data reported by Ad-hoc-news on September 17, 2026.

Recent share price performance

With the CHF 204.00 close on September 15, 2026 on the SIX Swiss Exchange, Tecan stock is trading above the prior session’s level by 3.6 percent, illustrating that investors have recently been willing to pay a higher price for the shares compared with the immediately preceding trading day, as highlighted by Ad-hoc-news.

In this context, the roughly CHF 204.00 level positions the shares within their broader trading history of the last year, giving investors a reference point for evaluating whether the current valuation reflects the company’s operational progress and earnings trajectory since its latest quarterly and annual reports as summarized by company materials on Tecan.

Earnings trends and revenue growth

According to the company’s most recent published financial results covering its latest fiscal periods, Tecan reported revenue for its most recent full fiscal year within the last 24 months, as well as interim revenue in the last 9 months, giving investors a current snapshot of the business that aligns with the CHF 204.00 share price as of September 15, 2026, with these figures presented in the financial reports accessible via Tecan.

In those latest reports, Tecan detailed its earnings before interest and taxes (EBIT) and net profit for the most recent fiscal year and interim period, including the margin development compared with the prior year or prior interim period, which allows investors to quantify how profitability is trending alongside the revenue changes presented for the same periods, based on figures laid out in the company’s reporting on Tecan.

The company has also communicated guidance ranges or outlook comments for the current year in these investor materials, which set expectations for revenue and earnings relative to the prior fiscal year’s actual numbers, helping investors compare forecast growth rates against the historical performance and assess whether the CHF 204.00 share price on September 15, 2026 appears supported by the anticipated trajectory, as outlined in guidance sections of the resources available through Tecan.

Analyst perspective and valuation context

Analyst coverage of Tecan stock contributes an additional perspective on valuation, with research analysts in the healthcare and life sciences tools space evaluating the shares relative to peers and issuing ratings and price targets based on their detailed models, as exemplified by sector coverage that includes Tecan Group AG alongside other companies such as Qiagen and Moderna in health care research mentioned in an article from The Globe and Mail on September 17, 2026.

Market data portals also provide rating summaries and risk assessments that give investors at-a-glance information on how Tecan stock is being viewed, including assessments such as a fair-price valuation band and medium risk descriptors associated with the Moody s Analytics risk score, which can be found on the stock overview page for Tecan on Finanzen.net.

Historically, analyst ratings for Tecan have included recommendations such as hold and neutral from houses including Vontobel Research and Sarasin Research, with examples cited from earlier years like a Tecan Group hold rating by Vontobel Research and a neutral view by Sarasin Research, as recorded in the historical rating table on Finanzen.net, which, while dated, still offer investors context on how the stock was previously perceived.

Stock level and investor takeaway

From an investor perspective, the CHF 204.00 closing price for Tecan stock on the SIX Swiss Exchange on September 15, 2026, following a 3.6 percent day-on-day gain, is a key reference level when weighing the company’s latest revenue growth, margin development and guidance from its most recent reports, and when considering risk assessments and analytic commentary provided by financial portals and sector research houses.

Tecan stock key data

  • Company: Tecan AG
  • ISIN: CH0012100191
  • Ticker: TECN
  • Trading venue: SIX Swiss Exchange
  • Price (as of September 15, 2026): 204.00 CHF
  • Sector / Industry: Health Care equipment and life science tools
  • Index membership: SPI

More news and analyses on Tecan stock

Disclaimer...

en | CH0012100191 | TECAN | boerse | 70117249 | bgmi